Atrial Fibrillation 2016 (Management of)

ESC Clinical Practice Guidelines

Despite good progress in the management of patients with atrial fibrillation (AF), this arrhythmia remains one of the major causes of stroke, heart failure, sudden death, and cardiovascular morbidity in the world.

These 2016 Atrial Fibrillation Guidelines are based on the current state-of-the-art evidence in 2016.

Topic(s): Arrhythmias, General; Antiarrhythmic Pharmacotherapy; Atrial Fibrillation; Anticoagulants; Pharmacology and Pharmacotherapy; Invasive Imaging and Functional Assessment; Stroke; Arrhythmias and Device Therapy


 

Outras Notícias
Artigos Revista SPC